SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001447028-19-000069
Filing Date
2019-11-06
Accepted
2019-11-06 07:34:56
Documents
19
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k.htm 8-K 31277
2 EXHIBIT 99.1 ex991-earningsrelease.htm EX-99.1 197734
3 EXHIBIT 99.2 ex992corporatepresentati.htm EX-99.2 23226
4 arbutuslogo.jpg GRAPHIC 15988
5 ex992corporatepresentati001.jpg GRAPHIC 57737
6 ex992corporatepresentati002.jpg GRAPHIC 184094
7 ex992corporatepresentati003.jpg GRAPHIC 86791
8 ex992corporatepresentati004.jpg GRAPHIC 99910
9 ex992corporatepresentati005.jpg GRAPHIC 123360
10 ex992corporatepresentati006.jpg GRAPHIC 76572
11 ex992corporatepresentati007.jpg GRAPHIC 61311
12 ex992corporatepresentati008.jpg GRAPHIC 57971
13 ex992corporatepresentati009.jpg GRAPHIC 73036
14 ex992corporatepresentati010.jpg GRAPHIC 63302
15 ex992corporatepresentati011.jpg GRAPHIC 78291
16 ex992corporatepresentati012.jpg GRAPHIC 68500
17 ex992corporatepresentati013.jpg GRAPHIC 90081
18 ex992corporatepresentati014.jpg GRAPHIC 92142
19 ex992corporatepresentati015.jpg GRAPHIC 61363
  Complete submission text file 0001447028-19-000069.txt   2032569
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 191195086
SIC: 2834 Pharmaceutical Preparations